Urgent.News

the world's headlines, one feed

Editions

Science

Earthquake of magnitude 7.4 shakes Colombia's Choco province, severe damage and injuries reported

Foreign Minister Gideon Sa'ar shared his concerns about the earthquake in a statement and offered his Colombian counterpart any assistance Israel could provide in the aftermath of quake.

At 7:34 a.m. on Monday, an earthquake with a magnitude of 7.4 struck Colombia's coastal Choco province, according to the Colombian Geological Service. The epicenter of the quake was located near San José del Palmar, situated at a depth of 79 km. Following the initial tremor, a secondary seismic incident measuring 4.6 on the Richter scale occurred in the same region, the geological service reported.

Colombia's National Unit for Disaster Risk Management (UNGRD) has confirmed that there is no threat of a tsunami resulting from the earthquake. The governor of Choco province, Nubia Carolina Córdoba-Curi, reported extensive damage to buildings and many injuries sustained by residents in the aftermath of the quake. She emphasized that damage assessments are currently underway to determine the full extent of the destruction.

Foreign Minister Gideon Saar expressed his concerns over the earthquake in a statement posted on X/Twitter, assuring Colombia that Israel is prepared to provide any assistance required. Saar added, "Israel is prepared to assist Colombia as much as required," and extended his thoughts and prayers to the Colombian people during this challenging period.

Written by urgent.news from Jerusalem Post's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at jpost.com →

More in Science

New GLP-1 pill delivers up to 12% weight loss in 36 weeks

An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks.

  • Aleniglipron oral GLP-1 treatment helps adults lose up to 12% body weight in 36 weeks
  • Developed by Structure Therapeutics, aleniglipron is small-molecule drug vs injectable GLP-1 drugs
  • Phase II trial with 230 participants showed average 9.0% weight loss in lowest dose group